ARCHIVES

Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

Congress Approves Payments For Treatment Of Women Diagnosed In CDC Program.

October 13, 2000

Major Changes In NCI Drug screening Tumor Panels Approved

June 18, 1982

Vanderbilt Wins Lung Cancer SPORE Grant.

May 18, 2001

ASCO Urges Doubling Cooperative Group Program Budget

April 16, 2010